pravastatin sold brand name pravachol among others statin medication used preventing cardiovascular disease high risk treating abnormal suggested used together diet changes exercise weight taken common side effects include joint pain diarrhea nausea headaches muscle serious side effects may include rhabdomyolysis liver problems use pregnancy may harm like statins pravastatin works inhibiting hmgcoa reductase enzyme found liver plays role producing pravastatin patented approved medical use world health organizations list essential available generic commonly prescribed medication united states million pravastatin primarily used treatment dyslipidemia prevention cardiovascular recommended used measures diet exercise weight reduction improved cholesterol pravastatin shown similar effectiveness lowering lowdensity lipoprotein cholesterol statin medications fluvastatin may low level evidence indicates pravastatin may effective statin medications beneficial effect pravastatin dependent dose potential side effects unwanted effects medication clear clinical pravastatin undergone patientyears doubleblind randomized trials using mg oncedaily dose placebos trials indicate pravastatin well tolerated displays noncardiovascular abnormalities however side effects may occur doctor consulted symptoms heartburn headache severe go awaymedical citation needed uncommon side effects promptly reported prescribing doctor emergency medical symptoms reported prescribing doctor persist increase severitymedical citation needed contraindications conditions warrant withholding treatment pravastatin include pregnancy taking pravastatin pregnant could lead birth defects amount pravastatin ingested infant breastfeeding low patients breastfeeding take pravastatin due potential effects infants lipid medications taken pravastatin include limited pravastatin cleared kidneys giving distinct advantage statins potential drug interactions using hepatic pathway existsmedical citation needed combination fenofibrate pravastatin approved use european pravastatin acts lipoproteinlowering drug two pathways major pathway pravastatin inhibits function hydroxymethylglutarylcoa hmgcoa reductase reversible competitive inhibitor pravastatin sterically hinders action hmgcoa reductase occupying active site enzyme taking place primarily liver enzyme responsible conversion hmgcoa mevalonate ratelimiting step biosynthetic pathway cholesterol pravastatin also inhibits synthesis verylowdensity lipoproteins precursor lowdensity lipoproteins ldl reductions increase number cellular ldl receptors thus ldl uptake increases removing overall result reduction circulating cholesterol ldl minor reduction triglycerides increase highdensity lipoproteins hdl common initially known pravastatin derivative compactin identified fungus called penicillium citrinum researchers sankyo pharma marketed outside japan pharmaceutical company bristolmyers squibb pravachol selling brandname drug united states sales totaling food drug administration fda approved generic pravastatin use united states april generic pravastatin sodium tablets manufactured biocon ltd india teva pharmaceuticals kfar sava httpsenwikipediaorgwikipravastatin